Jury Awards $47.5M in Vioxx Case

By Admin on March 13, 2007 | Last updated on March 21, 2019

A New Jersey jury yesterday awarded $47.5 million to a retired Idaho postal worker and his wife, finding that Vioxx manufacturer Merck & Co., Inc. failed to provide adequate warnings about the painkiller's risks, and that Vioxx use was a factor in plaintiff Frederick Humeston's 2001 heart attack. An initial award of $20 million in compensatory damages was increased to a total of $47.5 million after the jury ordered Merck to pay $27.5 million in punitive damages. The jury verdict was the fifth entered against Merck since Vioxx was pulled from the marketplace in September 2004, due to concerns over patient safety.

Copied to clipboard